CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

INCIDENCE AND NATURAL HISTORY OF LEFT VENTRICULAR NON-COMPACTION PRESENTING DURING CHILDHOOD.

P. Daubeney*, A. Nugent, P. Chondros, L. Wilkinson, A.M. Davis, S. Kleinert, C.W. Chow, J.L. Wilkinson, R. Weintraub.

Departments of Cardiology, Clinical Epidemiology & Biostatistics, and Anatomic Pathology, Royal Children's Hospital, Melbourne, Vic.

Left-ventricular non-compaction (LVNC) has previously been considered a rare medical curiosity whose cause and outcome are unknown.  This review examines the clinical features and outcomes for children with LVNC who were enrolled in the National Australian Childhood Cardiomyopathy Study. This is an ongoing population-based study which includes all children within Australia with primary cardiomyopathy who presented at 0-10 years of age.  The diagnosis was based on the presence of characteristic honeycomb or spongiform appearance of ventricular myocardium on echocardiography, angiography, cardiac MRI or direct examination.  The prognostic factors sought included age at presentation, gender, dominant pathophysiology (DCM or RCM), ventricular systolic dysfunction at presentation, number of affected myocardial segments and presence of Barth syndrome.  A total of 21 patients were identified, representing 6.5% of the NACCS study population.  The diagnosis was made from echocardiography in 21, ventricular angiography in 11, cardiac MRI in 1 and direct examination (transplant/post-mortem) in 4.  The median age at presentation was 0.4 years (range 1 day - 9.7 years).  CHF was the presenting symptom in 17/21 (81%) and 14 patients (67%) presented prior to 12 months of age.  Barth syndrome was present in 5/21 (24%).  The dominant pathophysiology was DCM in 16 (76%), RCM in 4 (19%) with one child (5%) having normal cardiac function.  Survival free from cardiac transplantation was 55% at 10 years of age and 30% after 15 years. Survival free from late cardiac dysfunction (defined by death, transplant, FS<25% or arrhythmias requiring therapy) was 35% at 10 years and 15% at 16 years.  Barth syndrome was the only variable related to outcome.  Children with Barth syndrome had a superior 10 year survival (100% vs 25%) and freedom from cardiac dysfunction (75% vs 12%; P<.02 for both) compared to the remaining study population.  We conclude that LVNC is more frequent than previously recognised.  Patients without Barth syndrome have a poor prognosis and merit early consideration of cardiac transplantation.

[ Back to 48th ASM Abstract Index ]


Med-E-Serv